Mills Robert S's Form 4 filing
TFF Pharmaceuticals, Inc. (TFFP) · filed Aug 15, 2023
- Accession no.
- 0001213900-23-067442
- Filed
- Aug 15, 2023, 8:00 AM ET
- Trade date
- Aug 15, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $10.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mills Robert SCIK 0001240140 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $0.25F1 | +$10,000 | 55,980 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.
Referenced by the price of 1 transaction in Table I.